ReviewPharmaceutics2022
Recent Advances in Nanoparticles-Based Platforms Targeting the PD-1/PD-L1 Pathway for Cancer Treatment.
Xin Yu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this papercites it
ReviewPharmaceutics2022
Xin Yu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.